Last quarter (Q0 0), Pharmchem's total revenue was $6.94M, a decrease of -5.11% from the same quarter last year. In Q0, Pharmchem's net income was $249.00K. See Pharmchem’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 02	Dec 01	Dec 00	Dec 99	Dec 98
Total Revenue	$ 27.62M	$ 30.09M	$ 36.57M	$ 39.39M	$ 44.49M	$ ―
Cost of Revenue	$ 21.25M	$ 23.01M	$ 32.53M	$ 28.97M	$ 31.37M	$ ―
Gross Profit	$ 6.36M	$ 7.07M	$ 4.04M	$ 10.43M	$ 13.11M	$ ―
Operating Expense	$ 7.48M	$ 7.86M	$ 12.13M	$ 9.63M	$ 10.36M	$ ―
Operating Income	$ -1.12M	$ -783.00K	$ -8.10M	$ 797.00K	$ 2.75M	$ 1.20M
Net Non Operating Interest Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Other Income Expense	$ 1.03M	$ 1.09M	$ -139.00K	$ 509.00K	$ 511.00K	$ ―
Pretax Income	$ -990.00K	$ -1.36M	$ -9.56M	$ 558.00K	$ 2.51M	$ 900.00K
Tax Provision	-	$ -69.00K	$ -87.00K	$ 264.00K	$ -294.00K	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -990.00K	$ 3.34M	$ -8.48M	$ 1.36M	$ 2.80M	$ ―
Basic EPS	$ -0.17	$ 0.57	$ -1.45	$ 0.23	$ 0.48	$ 0.11
Diluted EPS	$ -0.17	$ 0.57	$ -1.45	$ 0.22	$ 0.47	$ 0.10
Basic Average Shares	$ 23.41M	$ 5.85M	$ 5.85M	$ 5.82M	$ 5.79M	$ ―
Diluted Average Shares	$ 23.48M	$ 5.85M	$ 5.85M	$ 6.07M	$ 5.95M	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 28.74M	$ 30.87M	$ 44.66M	$ 38.60M	$ 41.73M	$ ―
Net Income From Continuing And Discontinued Operation	$ -990.00K	$ 3.34M	$ -8.48M	$ 1.36M	$ 2.80M	$ ―
Normalized Income	$ -1.97M	$ -2.33M	$ -9.34M	$ -30.78K	$ 2.35M	$ 600.00K
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -1.12M	$ -783.00K	$ -8.10M	$ 797.00K	$ 2.75M	$ ―
EBITDA	$ 1.01M	$ 1.47M	$ -6.07M	$ 2.75M	$ 4.81M	$ ―

Currency in USD

Pharmchem Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing